The UK BioIndustry Association (BIA) has launched a new guide to assist bioscience companies communicate their R&D progress to its investors and the public.
Driven by the UK’s ‘booming’ bioscience landscape, the Best Practice Guide presents four principles for high-quality communications that both public and private bioscience companies should follow.
“Be well prepared” and “be consistent” are among the advice that the guide offers, along with “be fair, balanced and understandable” and “be mindful of the impact on members of the public to whom it is personally relevant”.
Dr Chris Gardner, partner at Consilium Strategic Communications, said: “With bioscience companies expected to play an ever more pivotal role in the UK economy, the need for clear and effective communication has never been greater.
“Distilling complex ideas in high science companies for multiple audiences can be challenging, but there are some basic approaches which can help them keep their messages clear and simple.”
The BIA said its new guide is designed to help bioscience groups meet sector best practice and to apply their communications to the R&D process in particular.
Steve Bates, chief executive officer of BIA, said: “To establish the UK as the third global bioscience cluster we need investors and the public to be well informed and confident about the great science our companies our doing.”
The Best Practice Guide’s launch comes ahead of this month’s 36th annual JP Morgan Healthcare conference, a high point of the biotech calendar that will see entrepreneurs and investors from the UK sector attend.
Bates added: “As the entrepreneurial leaders and investors attend the JP Morgan in San Francisco, we hope the this guide helps them communicate the great investment opportunities there are here in Britain.”